183 related articles for article (PubMed ID: 20470896)
1. Lipid-induced up-regulation of human acyl-CoA synthetase 5 promotes hepatocellular apoptosis.
Reinartz A; Ehling J; Leue A; Liedtke C; Schneider U; Kopitz J; Weiss T; Hellerbrand C; Weiskirchen R; Knüchel R; Gassler N
Biochim Biophys Acta; 2010 Sep; 1801(9):1025-35. PubMed ID: 20470896
[TBL] [Abstract][Full Text] [Related]
2. Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicing.
Gassler N; Roth W; Funke B; Schneider A; Herzog F; Tischendorf JJ; Grund K; Penzel R; Bravo IG; Mariadason J; Ehemann V; Sykora J; Haas TL; Walczak H; Ganten T; Zentgraf H; Erb P; Alonso A; Autschbach F; Schirmacher P; Knüchel R; Kopitz J
Gastroenterology; 2007 Aug; 133(2):587-98. PubMed ID: 17681178
[TBL] [Abstract][Full Text] [Related]
3. Death receptor 5 signaling promotes hepatocyte lipoapoptosis.
Cazanave SC; Mott JL; Bronk SF; Werneburg NW; Fingas CD; Meng XW; Finnberg N; El-Deiry WS; Kaufmann SH; Gores GJ
J Biol Chem; 2011 Nov; 286(45):39336-48. PubMed ID: 21941003
[TBL] [Abstract][Full Text] [Related]
4. Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways.
Bu SY; Mashek DG
J Lipid Res; 2010 Nov; 51(11):3270-80. PubMed ID: 20798351
[TBL] [Abstract][Full Text] [Related]
5. Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells.
Mashek DG; McKenzie MA; Van Horn CG; Coleman RA
J Biol Chem; 2006 Jan; 281(2):945-50. PubMed ID: 16263710
[TBL] [Abstract][Full Text] [Related]
6. Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity.
Malhi H; Barreyro FJ; Isomoto H; Bronk SF; Gores GJ
Gut; 2007 Aug; 56(8):1124-31. PubMed ID: 17470478
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.
Zhou Y; Abidi P; Kim A; Chen W; Huang TT; Kraemer FB; Liu J
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2198-205. PubMed ID: 17761945
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of hepatic fatty acid transporters and inhibition/down-regulation of hepatic OCTN2 contribute to olanzapine-induced liver steatosis.
Jiang T; Zhang Y; Bai M; Li P; Wang W; Chen M; Ma Z; Zeng S; Zhou H; Jiang H
Toxicol Lett; 2019 Nov; 316():183-193. PubMed ID: 31437515
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia/reoxygenation up-regulated the expression of death receptor 5 and enhanced apoptosis in human hepatocyte line.
Cao L; Li Y; Cheng F; Li S; Long D
Transplant Proc; 2006 Sep; 38(7):2207-9. PubMed ID: 16980044
[TBL] [Abstract][Full Text] [Related]
11. Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.
Mashima T; Sato S; Sugimoto Y; Tsuruo T; Seimiya H
Oncogene; 2009 Jan; 28(1):9-19. PubMed ID: 18806831
[TBL] [Abstract][Full Text] [Related]
12. Levels of acyl-coenzyme A synthetase 5 in urothelial cells and corresponding neoplasias reflect cellular differentiation.
Gaisa NT; Reinartz A; Schneider U; Klaus C; Heidenreich A; Jakse G; Kaemmerer E; Klinkhammer BM; Knuechel R; Gassler N
Histol Histopathol; 2013 Mar; 28(3):353-64. PubMed ID: 23348389
[TBL] [Abstract][Full Text] [Related]
13. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.
Li ZZ; Berk M; McIntyre TM; Feldstein AE
J Biol Chem; 2009 Feb; 284(9):5637-44. PubMed ID: 19119140
[TBL] [Abstract][Full Text] [Related]
14. TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas.
Klaus C; Kaemmerer E; Reinartz A; Schneider U; Plum P; Jeon MK; Hose J; Hartmann F; Schnölzer M; Wagner N; Kopitz J; Gassler N
Cell Tissue Res; 2014 Jul; 357(1):267-78. PubMed ID: 24770931
[TBL] [Abstract][Full Text] [Related]
15. PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.
Kan CF; Singh AB; Dong B; Shende VR; Liu J
Biochim Biophys Acta; 2015 May; 1851(5):577-87. PubMed ID: 25645621
[TBL] [Abstract][Full Text] [Related]
16. MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis.
Podrini C; Koffas A; Chokshi S; Vinciguerra M; Lelliott CJ; White JK; Adissu HA; Williams R; Greco A
FASEB J; 2015 May; 29(5):1676-87. PubMed ID: 25526730
[TBL] [Abstract][Full Text] [Related]
17. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.
Kaemmerer E; Peuscher A; Reinartz A; Liedtke C; Weiskirchen R; Kopitz J; Gassler N
World J Gastroenterol; 2011 Nov; 17(44):4883-9. PubMed ID: 22171129
[TBL] [Abstract][Full Text] [Related]
18. The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5.
Xia Q; Chesi A; Manduchi E; Johnston BT; Lu S; Leonard ME; Parlin UW; Rappaport EF; Huang P; Wells AD; Blobel GA; Johnson ME; Grant SFA
Diabetologia; 2016 Nov; 59(11):2360-2368. PubMed ID: 27539148
[TBL] [Abstract][Full Text] [Related]
19. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
Higuchi H; Bronk SF; Taniai M; Canbay A; Gores GJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
[TBL] [Abstract][Full Text] [Related]
20. Steatotic liver allografts up-regulate UCP-2 expression and suffer necrosis in rats.
Uchino S; Yamaguchi Y; Furuhashi T; Wang FS; Zhang JL; Okabe K; Kihara S; Yamada S; Mori K; Ogawa M
J Surg Res; 2004 Jul; 120(1):73-82. PubMed ID: 15172192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
